Online smoking cessation program for Korean Americans: Randomized trial to test effects of incentives for program completion and interim surveys.
Online smoking cessation program for Korean Americans: Randomized trial to test effects of incentives for program completion and interim surveys.
复制标题
韩裔美国人在线戒烟计划:随机试验,测试计划完成激励措施和中期调查的效果。
DOI:
10.1016/j.ypmed.2016.01.019
复制
发表时间:
2016
影响因子:
5.1
通讯作者:
Lee,Hyun-Ju
中科院分区:
文献类型:
--
作者:
Moskowitz,JoelM;McDonnell,DianaD;Kazinets,Gene;Lee,Hyun-Ju
IntroductionSmoking is prevalent among Korean American men. Quitting is Winning, an Internet-based, cognitive-behavioral smoking cessation program, was developed using community-based participatory research principles.MethodsA randomized controlled trial was used to evaluate whether participants were more likely to complete the program and quit smoking at 6-months of follow-up with additional reinforcement. The main outcomes were the proportion of participants who completed the online program and the proportion who quit smoking for at least 30 days, 26 weeks after enrollment, among those randomized into the high-reinforcement (HR) condition compared with those in the low-reinforcement (LR) condition.ResultsThe study achieved a final enrollment of 403 participants including 56 women. Program completion was greater for the HR as compared to the LR condition (17% vs. 10%,p= .035). There was no significant difference in 30-day smoking cessation (intent-to-treat [ITT]) between the HR and LR conditions (9% vs. 8%, ns). Smoking cessation was greater among program completers as compared to those who did not complete the program (28% vs. 5%,p< .001).ConclusionsThe addition of interim surveys and financial incentives for interim survey completion and program completion significantly increased the likelihood of program completion. Moreover, program completers were significantly more likely to quit smoking. Although smoking cessation rates did not significantly differ between the HR and LR conditions, the results suggest that future studies should explore the efficacy of larger financial incentives for program completion (Clinical Trial #NCT02584127).